Proactiveinvestors Australia ValiRx PLC https://www.proactiveinvestors.com.au Proactiveinvestors Australia ValiRx PLC RSS feed en Sat, 11 Jul 2020 15:09:51 +1000 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) ValiRx working on options to hold a meeting to vote on vital cash lifeline https://www.proactiveinvestors.com.au/companies/news/916066/valirx-working-on-options-to-hold-a-meeting-to-vote-on-vital-cash-lifeline-916066.html Mon, 30 Mar 2020 07:12:00 +1100 https://www.proactiveinvestors.com.au/companies/news/916066/valirx-working-on-options-to-hold-a-meeting-to-vote-on-vital-cash-lifeline-916066.html ValiRx says its treatment had a “clear impact on patients with prostate cancer” https://www.proactiveinvestors.com.au/companies/news/909236/valirx-says-its-treatment-had-a-clear-impact-on-patients-with-prostate-cancer-909236.html Mon, 16 Dec 2019 07:23:00 +1100 https://www.proactiveinvestors.com.au/companies/news/909236/valirx-says-its-treatment-had-a-clear-impact-on-patients-with-prostate-cancer-909236.html ValiRx updates on JV discussions and switches NOMAD https://www.proactiveinvestors.com.au/companies/news/900170/valirx-updates-on-jv-discussions-and-switches-nomad-900170.html Tue, 06 Aug 2019 06:29:00 +1000 https://www.proactiveinvestors.com.au/companies/news/900170/valirx-updates-on-jv-discussions-and-switches-nomad-900170.html ValiRx wins European patent protection for potential endometriosis treatment https://www.proactiveinvestors.com.au/companies/news/224853/valirx-wins-european-patent-protection-for-potential-endometriosis-treatment-224853.html Thu, 01 Aug 2019 08:29:00 +1000 https://www.proactiveinvestors.com.au/companies/news/224853/valirx-wins-european-patent-protection-for-potential-endometriosis-treatment-224853.html ValiRx readying itself for VAL301 clinical trials https://www.proactiveinvestors.com.au/companies/news/223325/valirx-readying-itself-for-val301-clinical-trials-223325.html Thu, 04 Jul 2019 11:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/223325/valirx-readying-itself-for-val301-clinical-trials-223325.html ValiRx secures US patent for VAL201 cancer drug https://www.proactiveinvestors.com.au/companies/news/222823/valirx-secures-us-patent-for-val201-cancer-drug-222823.html Wed, 26 Jun 2019 11:45:00 +1000 https://www.proactiveinvestors.com.au/companies/news/222823/valirx-secures-us-patent-for-val201-cancer-drug-222823.html ValiRx agrees break fee as it terminates financing agreement https://www.proactiveinvestors.com.au/companies/news/222791/valirx-agrees-break-fee-as-it-terminates-financing-agreement-222791.html Tue, 25 Jun 2019 14:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/222791/valirx-agrees-break-fee-as-it-terminates-financing-agreement-222791.html ValiRx shares jump as firm cleared to increase clinical trial dosing https://www.proactiveinvestors.com.au/companies/news/222475/valirx-shares-jump-as-firm-cleared-to-increase-clinical-trial-dosing-222475.html Thu, 20 Jun 2019 07:20:00 +1000 https://www.proactiveinvestors.com.au/companies/news/222475/valirx-shares-jump-as-firm-cleared-to-increase-clinical-trial-dosing-222475.html ValiRX raises funds to meet immediate working capital needs and develop drugs https://www.proactiveinvestors.com.au/companies/news/222040/valirx-raises-funds-to-meet-immediate-working-capital-needs-and-develop-drugs-222040.html Thu, 13 Jun 2019 07:21:00 +1000 https://www.proactiveinvestors.com.au/companies/news/222040/valirx-raises-funds-to-meet-immediate-working-capital-needs-and-develop-drugs-222040.html ValiRx monitors working capital position amid talks to end subscription agreement with investor https://www.proactiveinvestors.com.au/companies/news/221760/valirx-monitors-working-capital-position-amid-talks-to-end-subscription-agreement-with-investor-221760.html Mon, 10 Jun 2019 06:45:00 +1000 https://www.proactiveinvestors.com.au/companies/news/221760/valirx-monitors-working-capital-position-amid-talks-to-end-subscription-agreement-with-investor-221760.html ValiRx outlines next step for prostate cancer drug https://www.proactiveinvestors.com.au/companies/news/221104/valirx-outlines-next-step-for-prostate-cancer-drug-221104.html Wed, 29 May 2019 06:42:00 +1000 https://www.proactiveinvestors.com.au/companies/news/221104/valirx-outlines-next-step-for-prostate-cancer-drug-221104.html ValiRx in talks to terminate subscription agreement and enter into a new convertible bond facility https://www.proactiveinvestors.com.au/companies/news/221013/valirx-in-talks-to-terminate-subscription-agreement-and-enter-into-a-new-convertible-bond-facility-221013.html Tue, 28 May 2019 06:47:00 +1000 https://www.proactiveinvestors.com.au/companies/news/221013/valirx-in-talks-to-terminate-subscription-agreement-and-enter-into-a-new-convertible-bond-facility-221013.html ValiRx updates on second round of funding discussions https://www.proactiveinvestors.com.au/companies/news/220747/valirx-updates-on-second-round-of-funding-discussions-220747.html Wed, 22 May 2019 06:33:00 +1000 https://www.proactiveinvestors.com.au/companies/news/220747/valirx-updates-on-second-round-of-funding-discussions-220747.html ValiRx primed for a pivotal year https://www.proactiveinvestors.com.au/companies/news/219118/valirx-primed-for-a-pivotal-year-219118.html Thu, 02 May 2019 17:51:00 +1000 https://www.proactiveinvestors.com.au/companies/news/219118/valirx-primed-for-a-pivotal-year-219118.html ValiRx makes acquisition and inks joint-venture deal https://www.proactiveinvestors.com.au/companies/news/219534/valirx-makes-acquisition-and-inks-joint-venture-deal-219534.html Thu, 02 May 2019 06:21:00 +1000 https://www.proactiveinvestors.com.au/companies/news/219534/valirx-makes-acquisition-and-inks-joint-venture-deal-219534.html ValiRx secures cash to fund VAL201 trial through to completion https://www.proactiveinvestors.com.au/companies/news/219174/valirx-secures-cash-to-fund-val201-trial-through-to-completion-219174.html Fri, 26 Apr 2019 09:20:00 +1000 https://www.proactiveinvestors.com.au/companies/news/219174/valirx-secures-cash-to-fund-val201-trial-through-to-completion-219174.html Valirx says letters of intent signed to fund final stage trial of lung cancer drug https://www.proactiveinvestors.com.au/companies/news/217206/valirx-says-letters-of-intent-signed-to-fund-final-stage-trial-of-lung-cancer-drug-217206.html Tue, 26 Mar 2019 08:03:00 +1100 https://www.proactiveinvestors.com.au/companies/news/217206/valirx-says-letters-of-intent-signed-to-fund-final-stage-trial-of-lung-cancer-drug-217206.html ValiRx boss “delighted” with progress of cancer drug VAL201 and VAL301 for endometriosis https://www.proactiveinvestors.com.au/companies/news/216909/valirx-boss-delighted-with-progress-of-cancer-drug-val201-and-val301-for-endometriosis-216909.html Thu, 21 Mar 2019 13:55:00 +1100 https://www.proactiveinvestors.com.au/companies/news/216909/valirx-boss-delighted-with-progress-of-cancer-drug-val201-and-val301-for-endometriosis-216909.html ValiRx raises £0.5mln in share placing to further expand scope of clinical trial for its prostate cancer treatment https://www.proactiveinvestors.com.au/companies/news/215040/valirx-raises-05mln-in-share-placing-to-further-expand-scope-of-clinical-trial-for-its-prostate-cancer-treatment-215040.html Thu, 21 Feb 2019 12:03:00 +1100 https://www.proactiveinvestors.com.au/companies/news/215040/valirx-raises-05mln-in-share-placing-to-further-expand-scope-of-clinical-trial-for-its-prostate-cancer-treatment-215040.html ValiRx surges as it secures two new patents for VAL301 in Russia and China https://www.proactiveinvestors.com.au/companies/news/213694/valirx-surges-as-it-secures-two-new-patents-for-val301-in-russia-and-china-213694.html Thu, 31 Jan 2019 14:57:00 +1100 https://www.proactiveinvestors.com.au/companies/news/213694/valirx-surges-as-it-secures-two-new-patents-for-val301-in-russia-and-china-213694.html ValiRX confirms online publication of peer-reviewed article https://www.proactiveinvestors.com.au/companies/news/212378/valirx-confirms-online-publication-of-peer-reviewed-article-212378.html Fri, 11 Jan 2019 07:43:00 +1100 https://www.proactiveinvestors.com.au/companies/news/212378/valirx-confirms-online-publication-of-peer-reviewed-article-212378.html New long-term NHS plan bodes well for ValiRx https://www.proactiveinvestors.com.au/companies/news/212231/new-long-term-nhs-plan-bodes-well-for-valirx-212231.html Wed, 09 Jan 2019 11:50:00 +1100 https://www.proactiveinvestors.com.au/companies/news/212231/new-long-term-nhs-plan-bodes-well-for-valirx-212231.html ValiRx hails publication of first peer-reviewed article on cancer treatment; raises £500k https://www.proactiveinvestors.com.au/companies/news/211372/valirx-hails-publication-of-first-peer-reviewed-article-on-cancer-treatment-raises-500k-211372.html Tue, 18 Dec 2018 12:18:00 +1100 https://www.proactiveinvestors.com.au/companies/news/211372/valirx-hails-publication-of-first-peer-reviewed-article-on-cancer-treatment-raises-500k-211372.html ValiRx hopes to expedite partner discussions with peer review of lung cancer treatment https://www.proactiveinvestors.com.au/companies/news/205610/valirx-hopes-to-expedite-partner-discussions-with-peer-review-of-lung-cancer-treatment-205610.html Tue, 18 Dec 2018 08:30:00 +1100 https://www.proactiveinvestors.com.au/companies/news/205610/valirx-hopes-to-expedite-partner-discussions-with-peer-review-of-lung-cancer-treatment-205610.html ValiRx’s VAL201 records “statistically significant” response in clinical trial https://www.proactiveinvestors.com.au/companies/news/210841/valirxs-val201-records-statistically-significant-response-in-clinical-trial-210841.html Mon, 10 Dec 2018 09:04:00 +1100 https://www.proactiveinvestors.com.au/companies/news/210841/valirxs-val201-records-statistically-significant-response-in-clinical-trial-210841.html ValiRx enters final stages of phase I/II trial of its VAL201 prostate cancer drug https://www.proactiveinvestors.com.au/companies/news/207251/valirx-enters-final-stages-of-phase-iii-trial-of-its-val201-prostate-cancer-drug-207251.html Wed, 17 Oct 2018 06:27:00 +1100 https://www.proactiveinvestors.com.au/companies/news/207251/valirx-enters-final-stages-of-phase-iii-trial-of-its-val201-prostate-cancer-drug-207251.html Results from ValiRx’s phase II study of VAL401 anti-cancer compound to be published on ClinicalTrials.gov https://www.proactiveinvestors.com.au/companies/news/207078/results-from-valirxs-phase-ii-study-of-val401-anti-cancer-compound-to-be-published-on-clinicaltrialsgov-207078.html Mon, 15 Oct 2018 11:33:00 +1100 https://www.proactiveinvestors.com.au/companies/news/207078/results-from-valirxs-phase-ii-study-of-val401-anti-cancer-compound-to-be-published-on-clinicaltrialsgov-207078.html ValiRx has raised £1.15mln via a share placing to accelerate its clinical and pre-clinical portfolio https://www.proactiveinvestors.com.au/companies/news/204934/valirx-has-raised-115mln-via-a-share-placing-to-accelerate-its-clinical-and-pre-clinical-portfolio-204934.html Fri, 14 Sep 2018 11:49:00 +1000 https://www.proactiveinvestors.com.au/companies/news/204934/valirx-has-raised-115mln-via-a-share-placing-to-accelerate-its-clinical-and-pre-clinical-portfolio-204934.html Commercial discussions for ValiRx's lead cancer drug progressing 'rapidly' https://www.proactiveinvestors.com.au/companies/news/310377/commercial-discussions-for-valirx-s-lead-cancer-drug-progressing-rapidly--10377.html Thu, 06 Sep 2018 11:50:00 +1000 https://www.proactiveinvestors.com.au/companies/news/310377/commercial-discussions-for-valirx-s-lead-cancer-drug-progressing-rapidly--10377.html ValiRx chief says company is at an exciting phase as it updates on two key cancer candidates https://www.proactiveinvestors.com.au/companies/news/204309/valirx-chief-says-company-is-at-an-exciting-phase-as-it-updates-on-two-key-cancer-candidates-204309.html Thu, 06 Sep 2018 06:10:00 +1000 https://www.proactiveinvestors.com.au/companies/news/204309/valirx-chief-says-company-is-at-an-exciting-phase-as-it-updates-on-two-key-cancer-candidates-204309.html ValiRx Plc enjoying strong industry interest in its cancer treatments https://www.proactiveinvestors.com.au/companies/news/309901/valirx-plc-enjoying-strong-industry-interest-in-its-cancer-treatments-9901.html Thu, 19 Jul 2018 12:01:00 +1000 https://www.proactiveinvestors.com.au/companies/news/309901/valirx-plc-enjoying-strong-industry-interest-in-its-cancer-treatments-9901.html ValiRx advances as it wins patent protection pre-clinical drug to treat endometriosis https://www.proactiveinvestors.com.au/companies/news/200915/valirx-advances-as-it-wins-patent-protection-pre-clinical-drug-to-treat-endometriosis-200915.html Tue, 17 Jul 2018 08:20:00 +1000 https://www.proactiveinvestors.com.au/companies/news/200915/valirx-advances-as-it-wins-patent-protection-pre-clinical-drug-to-treat-endometriosis-200915.html Valirx's talks in lung cancer highlight progress on all fronts https://www.proactiveinvestors.com.au/companies/news/200606/valirx-s-talks-in-lung-cancer-highlight-progress-on-all-fronts-200606.html Wed, 11 Jul 2018 12:26:00 +1000 https://www.proactiveinvestors.com.au/companies/news/200606/valirx-s-talks-in-lung-cancer-highlight-progress-on-all-fronts-200606.html ValiRx surges as it continues “advanced conversations” with possible partners for lung cancer drug https://www.proactiveinvestors.com.au/companies/news/198851/valirx-surges-as-it-continues-advanced-conversations-with-possible-partners-for-lung-cancer-drug-198851.html Thu, 14 Jun 2018 15:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/198851/valirx-surges-as-it-continues-advanced-conversations-with-possible-partners-for-lung-cancer-drug-198851.html ValiRx raises £0.95mln through a placing of 47.5mln new ordinary shares at 2.0p each https://www.proactiveinvestors.com.au/companies/news/196448/valirx-raises-095mln-through-a-placing-of-475mln-new-ordinary-shares-at-20p-each-196448.html Fri, 04 May 2018 15:11:00 +1000 https://www.proactiveinvestors.com.au/companies/news/196448/valirx-raises-095mln-through-a-placing-of-475mln-new-ordinary-shares-at-20p-each-196448.html ValiRx receives EU patent grant for prostate cancer drug https://www.proactiveinvestors.com.au/companies/news/195714/valirx-receives-eu-patent-grant-for-prostate-cancer-drug-195714.html Wed, 25 Apr 2018 06:42:00 +1000 https://www.proactiveinvestors.com.au/companies/news/195714/valirx-receives-eu-patent-grant-for-prostate-cancer-drug-195714.html ValiRx shoots higher, innovation effective at inducing programmed cell death in a wide range of cancers https://www.proactiveinvestors.com.au/companies/news/195338/valirx-shoots-higher-innovation-effective-at-inducing-programmed-cell-death-in-a-wide-range-of-cancers-195338.html Thu, 19 Apr 2018 08:15:00 +1000 https://www.proactiveinvestors.com.au/companies/news/195338/valirx-shoots-higher-innovation-effective-at-inducing-programmed-cell-death-in-a-wide-range-of-cancers-195338.html ValiRx PLC making 'striking and important' progress on lead cancer compounds https://www.proactiveinvestors.com.au/companies/news/309033/valirx-plc-making-striking-and-important-progress-on-lead-cancer-compounds-9033.html Tue, 10 Apr 2018 15:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/309033/valirx-plc-making-striking-and-important-progress-on-lead-cancer-compounds-9033.html ValiRx chairman upbeat on the potential of two lead compounds https://www.proactiveinvestors.com.au/companies/news/194595/valirx-chairman-upbeat-on-the-potential-of-two-lead-compounds-194595.html Tue, 10 Apr 2018 07:04:00 +1000 https://www.proactiveinvestors.com.au/companies/news/194595/valirx-chairman-upbeat-on-the-potential-of-two-lead-compounds-194595.html ValiRx receives US patent protection for exciting lead cancer drug https://www.proactiveinvestors.com.au/companies/news/193444/valirx-receives-us-patent-protection-for-exciting-lead-cancer-drug-193444.html Tue, 20 Mar 2018 07:43:00 +1100 https://www.proactiveinvestors.com.au/companies/news/193444/valirx-receives-us-patent-protection-for-exciting-lead-cancer-drug-193444.html ValiRx releases more positive data from VAL401 phase II lung cancer trial https://www.proactiveinvestors.com.au/companies/news/190085/valirx-releases-more-positive-data-from-val401-phase-ii-lung-cancer-trial-190085.html Tue, 16 Jan 2018 08:34:00 +1100 https://www.proactiveinvestors.com.au/companies/news/190085/valirx-releases-more-positive-data-from-val401-phase-ii-lung-cancer-trial-190085.html ValiRx given US patent boost for its lead therapeutic compound https://www.proactiveinvestors.com.au/companies/news/189857/valirx-given-us-patent-boost-for-its-lead-therapeutic-compound-189857.html Thu, 11 Jan 2018 14:20:00 +1100 https://www.proactiveinvestors.com.au/companies/news/189857/valirx-given-us-patent-boost-for-its-lead-therapeutic-compound-189857.html ValiRx puts convertible loan note facility with Yorkville to bed https://www.proactiveinvestors.com.au/companies/news/189299/valirx-puts-convertible-loan-note-facility-with-yorkville-to-bed-189299.html Wed, 27 Dec 2017 15:22:00 +1100 https://www.proactiveinvestors.com.au/companies/news/189299/valirx-puts-convertible-loan-note-facility-with-yorkville-to-bed-189299.html ValiRx brings in £1mln from share sale which will be used to help fund trial of prostate cancer drug https://www.proactiveinvestors.com.au/companies/news/189223/valirx-brings-in-1mln-from-share-sale-which-will-be-used-to-help-fund-trial-of-prostate-cancer-drug-189223.html Fri, 22 Dec 2017 08:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/189223/valirx-brings-in-1mln-from-share-sale-which-will-be-used-to-help-fund-trial-of-prostate-cancer-drug-189223.html ValiRx PLC gets go-ahead to expand and accelerate early-stage cancer study https://www.proactiveinvestors.com.au/companies/news/308561/valirx-plc-gets-go-ahead-to-expand-and-accelerate-early-stage-cancer-study-8561.html Tue, 19 Dec 2017 13:18:00 +1100 https://www.proactiveinvestors.com.au/companies/news/308561/valirx-plc-gets-go-ahead-to-expand-and-accelerate-early-stage-cancer-study-8561.html ValiRx given the green light to accelerate progress of prostate cancer drug after encouraging early results https://www.proactiveinvestors.com.au/companies/news/188925/valirx-given-the-green-light-to-accelerate-progress-of-prostate-cancer-drug-after-encouraging-early-results-188925.html Mon, 18 Dec 2017 12:45:00 +1100 https://www.proactiveinvestors.com.au/companies/news/188925/valirx-given-the-green-light-to-accelerate-progress-of-prostate-cancer-drug-after-encouraging-early-results-188925.html ValiRx surges once again as top-line data from Phase II lung cancer trial impresses https://www.proactiveinvestors.com.au/companies/news/188643/valirx-surges-once-again-as-top-line-data-from-phase-ii-lung-cancer-trial-impresses-188643.html Tue, 12 Dec 2017 15:15:00 +1100 https://www.proactiveinvestors.com.au/companies/news/188643/valirx-surges-once-again-as-top-line-data-from-phase-ii-lung-cancer-trial-impresses-188643.html ValiRx unveils positive results from VAL401 Phase II lung cancer trial https://www.proactiveinvestors.com.au/companies/news/308526/valirx-unveils-positive-results-from-val401-phase-ii-lung-cancer-trial-8526.html Tue, 12 Dec 2017 12:56:00 +1100 https://www.proactiveinvestors.com.au/companies/news/308526/valirx-unveils-positive-results-from-val401-phase-ii-lung-cancer-trial-8526.html ValiRx says YA II has converted second tranche of convertible loan facility at 1.25p per share https://www.proactiveinvestors.com.au/companies/news/188604/valirx-says-ya-ii-has-converted-second-tranche-of-convertible-loan-facility-at-125p-per-share-188604.html Mon, 11 Dec 2017 16:04:00 +1100 https://www.proactiveinvestors.com.au/companies/news/188604/valirx-says-ya-ii-has-converted-second-tranche-of-convertible-loan-facility-at-125p-per-share-188604.html ValiRx surges as it raises £1mln at a premium and confirms VAL401 phase II trial on track for readout this year https://www.proactiveinvestors.com.au/companies/news/188071/valirx-surges-as-it-raises-1mln-at-a-premium-and-confirms-val401-phase-ii-trial-on-track-for-readout-this-year-188071.html Thu, 30 Nov 2017 15:23:00 +1100 https://www.proactiveinvestors.com.au/companies/news/188071/valirx-surges-as-it-raises-1mln-at-a-premium-and-confirms-val401-phase-ii-trial-on-track-for-readout-this-year-188071.html ValiRx awarded fifth US patent for VAL401 cancer drug https://www.proactiveinvestors.com.au/companies/news/185385/valirx-awarded-fifth-us-patent-for-val401-cancer-drug-185385.html Wed, 11 Oct 2017 06:24:00 +1100 https://www.proactiveinvestors.com.au/companies/news/185385/valirx-awarded-fifth-us-patent-for-val401-cancer-drug-185385.html ValiRx opens higher as it completes dosing of VAL401 phase II cancer trial https://www.proactiveinvestors.com.au/companies/news/184736/valirx-opens-higher-as-it-completes-dosing-of-val401-phase-ii-cancer-trial-184736.html Thu, 28 Sep 2017 07:26:00 +1000 https://www.proactiveinvestors.com.au/companies/news/184736/valirx-opens-higher-as-it-completes-dosing-of-val401-phase-ii-cancer-trial-184736.html ValiRx praises “considerable progress” made in first half https://www.proactiveinvestors.com.au/companies/news/184587/valirx-praises-considerable-progress-made-in-first-half-184587.html Wed, 27 Sep 2017 14:10:00 +1000 https://www.proactiveinvestors.com.au/companies/news/184587/valirx-praises-considerable-progress-made-in-first-half-184587.html ValiRx raises £0.5mln via a placing of 50mln new ordinary shares at a price of 1p each https://www.proactiveinvestors.com.au/companies/news/184186/valirx-raises-05mln-via-a-placing-of-50mln-new-ordinary-shares-at-a-price-of-1p-each-184186.html Tue, 19 Sep 2017 06:28:00 +1000 https://www.proactiveinvestors.com.au/companies/news/184186/valirx-raises-05mln-via-a-placing-of-50mln-new-ordinary-shares-at-a-price-of-1p-each-184186.html ValiRx to accelerate pre-clinical trials of cancer-fighting molecule after development breakthrough https://www.proactiveinvestors.com.au/companies/news/183594/valirx-to-accelerate-pre-clinical-trials-of-cancer-fighting-molecule-after-development-breakthrough-183594.html Thu, 07 Sep 2017 11:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/183594/valirx-to-accelerate-pre-clinical-trials-of-cancer-fighting-molecule-after-development-breakthrough-183594.html Cancer-focused ValiRx inks licensing agreement with Bangladeshi group Mystic Pharmaceuticals https://www.proactiveinvestors.com.au/companies/news/181616/cancer-focused-valirx-inks-licensing-agreement-with-bangladeshi-group-mystic-pharmaceuticals-181616.html Fri, 28 Jul 2017 13:16:00 +1000 https://www.proactiveinvestors.com.au/companies/news/181616/cancer-focused-valirx-inks-licensing-agreement-with-bangladeshi-group-mystic-pharmaceuticals-181616.html ValiRx recruits three experienced industry figures to advisory board https://www.proactiveinvestors.com.au/companies/news/179657/valirx-recruits-three-experienced-industry-figures-to-advisory-board-179657.html Thu, 22 Jun 2017 06:49:00 +1000 https://www.proactiveinvestors.com.au/companies/news/179657/valirx-recruits-three-experienced-industry-figures-to-advisory-board-179657.html ValiRx says patient recruitment for lung cancer study has been completed https://www.proactiveinvestors.com.au/companies/news/179293/valirx-says-patient-recruitment-for-lung-cancer-study-has-been-completed-179293.html Thu, 15 Jun 2017 07:14:00 +1000 https://www.proactiveinvestors.com.au/companies/news/179293/valirx-says-patient-recruitment-for-lung-cancer-study-has-been-completed-179293.html ValIRx joint venture picks up patent in Australia for lung cancer compond https://www.proactiveinvestors.com.au/companies/news/178255/valirx-joint-venture-picks-up-patent-in-australia-for-lung-cancer-compond-178255.html Wed, 24 May 2017 09:19:00 +1000 https://www.proactiveinvestors.com.au/companies/news/178255/valirx-joint-venture-picks-up-patent-in-australia-for-lung-cancer-compond-178255.html ValiRx happy with prostate and lung cancer drug trial progress https://www.proactiveinvestors.com.au/companies/news/177371/valirx-happy-with-prostate-and-lung-cancer-drug-trial-progress-177371.html Fri, 05 May 2017 08:09:00 +1000 https://www.proactiveinvestors.com.au/companies/news/177371/valirx-happy-with-prostate-and-lung-cancer-drug-trial-progress-177371.html ValiRx offers low-risk, high return for investors, says analyst https://www.proactiveinvestors.com.au/companies/news/174616/valirx-offers-low-risk-high-return-for-investors-says-analyst-174616.html Fri, 10 Mar 2017 13:24:00 +1100 https://www.proactiveinvestors.com.au/companies/news/174616/valirx-offers-low-risk-high-return-for-investors-says-analyst-174616.html ValiRx to publish mid-trial data from lung cancer study https://www.proactiveinvestors.com.au/companies/news/174443/valirx-to-publish-mid-trial-data-from-lung-cancer-study-174443.html Wed, 08 Mar 2017 08:01:00 +1100 https://www.proactiveinvestors.com.au/companies/news/174443/valirx-to-publish-mid-trial-data-from-lung-cancer-study-174443.html ValiRx raises £1.2mln to support clinical trial programmes https://www.proactiveinvestors.com.au/companies/news/174031/valirx-raises-12mln-to-support-clinical-trial-programmes-174031.html Wed, 01 Mar 2017 14:46:00 +1100 https://www.proactiveinvestors.com.au/companies/news/174031/valirx-raises-12mln-to-support-clinical-trial-programmes-174031.html ValiRx's cancer treatment recognised in peer-reviewed journals https://www.proactiveinvestors.com.au/companies/news/173928/valirx-s-cancer-treatment-recognised-in-peer-reviewed-journals-173928.html Tue, 28 Feb 2017 13:27:00 +1100 https://www.proactiveinvestors.com.au/companies/news/173928/valirx-s-cancer-treatment-recognised-in-peer-reviewed-journals-173928.html ValiRx prostate cancer drug delivers eye-catching early results https://www.proactiveinvestors.com.au/companies/news/171449/valirx-prostate-cancer-drug-delivers-eye-catching-early-results-171449.html Wed, 11 Jan 2017 10:34:00 +1100 https://www.proactiveinvestors.com.au/companies/news/171449/valirx-prostate-cancer-drug-delivers-eye-catching-early-results-171449.html Yorkville converts loan notes into ValiRx shares https://www.proactiveinvestors.com.au/companies/news/171037/yorkville-converts-loan-notes-into-valirx-shares Fri, 30 Dec 2016 10:35:00 +1100 https://www.proactiveinvestors.com.au/companies/news/171037/yorkville-converts-loan-notes-into-valirx-shares ValiRx Plc celebrating 'particularly important' European patent https://www.proactiveinvestors.com.au/companies/news/306581/valirx-plc-celebrating-particularly-important-european-patent-6581.html Thu, 08 Dec 2016 14:15:00 +1100 https://www.proactiveinvestors.com.au/companies/news/306581/valirx-plc-celebrating-particularly-important-european-patent-6581.html ValiRx boosts worldwide patent protection for VAL201 https://www.proactiveinvestors.com.au/companies/news/170177/valirx-boosts-worldwide-patent-protection-for-val201-170177.html Thu, 08 Dec 2016 09:01:00 +1100 https://www.proactiveinvestors.com.au/companies/news/170177/valirx-boosts-worldwide-patent-protection-for-val201-170177.html ValiRx set to expand lung cancer trial in Georgia https://www.proactiveinvestors.com.au/companies/news/169820/valirx-set-to-expand-lung-cancer-trial-in-georgia-169820.html Thu, 01 Dec 2016 13:04:00 +1100 https://www.proactiveinvestors.com.au/companies/news/169820/valirx-set-to-expand-lung-cancer-trial-in-georgia-169820.html ValiRx's lead candidate study to be expanded https://www.proactiveinvestors.com.au/companies/news/169655/valirx-s-lead-candidate-study-to-be-expanded-169655.html Tue, 29 Nov 2016 07:32:00 +1100 https://www.proactiveinvestors.com.au/companies/news/169655/valirx-s-lead-candidate-study-to-be-expanded-169655.html ValiRx encouraged by progress in lung cancer trial https://www.proactiveinvestors.com.au/companies/news/168455/valirx-encouraged-by-progress-in-lung-cancer-trial-168455.html Thu, 03 Nov 2016 07:28:00 +1100 https://www.proactiveinvestors.com.au/companies/news/168455/valirx-encouraged-by-progress-in-lung-cancer-trial-168455.html ValiRx receives new patents in Japan and US for lead compounds https://www.proactiveinvestors.com.au/companies/news/167904/valirx-receives-new-patents-in-japan-and-us-for-lead-compounds-167904.html Tue, 25 Oct 2016 06:26:00 +1100 https://www.proactiveinvestors.com.au/companies/news/167904/valirx-receives-new-patents-in-japan-and-us-for-lead-compounds-167904.html ValiRx's recent data well received https://www.proactiveinvestors.com.au/companies/news/167349/valirx-s-recent-data-well-received-167349.html Thu, 13 Oct 2016 07:08:00 +1100 https://www.proactiveinvestors.com.au/companies/news/167349/valirx-s-recent-data-well-received-167349.html ValiRx reformulates key drug as endometriosis treatment https://www.proactiveinvestors.com.au/companies/news/166517/valirx-reformulates-key-drug-as-endometriosis-treatment-166517.html Tue, 27 Sep 2016 07:11:00 +1000 https://www.proactiveinvestors.com.au/companies/news/166517/valirx-reformulates-key-drug-as-endometriosis-treatment-166517.html ValiRx’s lead compound continues to perform well https://www.proactiveinvestors.com.au/companies/news/165773/valirxs-lead-compound-continues-to-perform-well-165773.html Tue, 13 Sep 2016 07:54:00 +1000 https://www.proactiveinvestors.com.au/companies/news/165773/valirxs-lead-compound-continues-to-perform-well-165773.html Green-light received for start of ValiRx's lung cancer trial https://www.proactiveinvestors.com.au/companies/news/129239/green-light-received-for-start-of-valirx-s-lung-cancer-trial-129239.html Thu, 11 Aug 2016 14:28:00 +1000 https://www.proactiveinvestors.com.au/companies/news/129239/green-light-received-for-start-of-valirx-s-lung-cancer-trial-129239.html Northland Capital Partners View on the City - ValiRx https://www.proactiveinvestors.com.au/companies/news/275709/northland-capital-partners-view-on-the-city-valirx-25709.html Thu, 11 Aug 2016 07:37:00 +1000 https://www.proactiveinvestors.com.au/companies/news/275709/northland-capital-partners-view-on-the-city-valirx-25709.html ValiRx Plc gets go-ahead for trials of lung cancer drug https://www.proactiveinvestors.com.au/companies/news/305381/valirx-plc-gets-go-ahead-for-trials-of-lung-cancer-drug-5381.html Thu, 11 Aug 2016 06:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/305381/valirx-plc-gets-go-ahead-for-trials-of-lung-cancer-drug-5381.html ValiRx receives notification of patent grant allowance in New Zealand for VAL401 https://www.proactiveinvestors.com.au/companies/news/128721/valirx-receives-notification-of-patent-grant-allowance-in-new-zealand-for-val401-128721.html Thu, 28 Jul 2016 06:20:00 +1000 https://www.proactiveinvestors.com.au/companies/news/128721/valirx-receives-notification-of-patent-grant-allowance-in-new-zealand-for-val401-128721.html ValiRx suspends use of loan facility with Bracknor https://www.proactiveinvestors.com.au/companies/news/128610/valirx-suspends-use-of-loan-facility-with-bracknor-128610.html Tue, 26 Jul 2016 06:44:00 +1000 https://www.proactiveinvestors.com.au/companies/news/128610/valirx-suspends-use-of-loan-facility-with-bracknor-128610.html Ethics Committee approval for ValiRx's Georgia site "very important" https://www.proactiveinvestors.com.au/companies/news/305284/ethics-committee-approval-for-valirx-s-georgia-site-very-important--5284.html Fri, 15 Jul 2016 09:02:00 +1000 https://www.proactiveinvestors.com.au/companies/news/305284/ethics-committee-approval-for-valirx-s-georgia-site-very-important--5284.html Northland Capital Partners View on the City - ValiRx plc https://www.proactiveinvestors.com.au/companies/news/275466/northland-capital-partners-view-on-the-city-valirx-plc-25466.html Thu, 14 Jul 2016 07:17:00 +1000 https://www.proactiveinvestors.com.au/companies/news/275466/northland-capital-partners-view-on-the-city-valirx-plc-25466.html ValiRx receives important sign-off for cancer trial https://www.proactiveinvestors.com.au/companies/news/128186/valirx-receives-important-sign-off-for-cancer-trial-128186.html Thu, 14 Jul 2016 06:51:00 +1000 https://www.proactiveinvestors.com.au/companies/news/128186/valirx-receives-important-sign-off-for-cancer-trial-128186.html ValiRx CEO says drug sell-off will raise cash and free-up resources https://www.proactiveinvestors.com.au/companies/news/305249/valirx-ceo-says-drug-sell-off-will-raise-cash-and-free-up-resources-5249.html Thu, 07 Jul 2016 15:07:00 +1000 https://www.proactiveinvestors.com.au/companies/news/305249/valirx-ceo-says-drug-sell-off-will-raise-cash-and-free-up-resources-5249.html ValiRx's sale of Finnish subsidiary will free up resources https://www.proactiveinvestors.com.au/companies/news/127936/valirx-s-sale-of-finnish-subsidiary-will-free-up-resources-127936.html Thu, 07 Jul 2016 07:05:00 +1000 https://www.proactiveinvestors.com.au/companies/news/127936/valirx-s-sale-of-finnish-subsidiary-will-free-up-resources-127936.html ValiRx in talks over cancer drug collaborations, says chief https://www.proactiveinvestors.com.au/companies/news/305124/valirx-in-talks-over-cancer-drug-collaborations-says-chief-5124.html Wed, 08 Jun 2016 13:51:00 +1000 https://www.proactiveinvestors.com.au/companies/news/305124/valirx-in-talks-over-cancer-drug-collaborations-says-chief-5124.html ValiRx starts preparations for efficacy trial of cancer drug https://www.proactiveinvestors.com.au/companies/news/126814/valirx-starts-preparations-for-efficacy-trial-of-cancer-drug-126814.html Tue, 07 Jun 2016 08:16:00 +1000 https://www.proactiveinvestors.com.au/companies/news/126814/valirx-starts-preparations-for-efficacy-trial-of-cancer-drug-126814.html ValiRx advancing both lead compounds https://www.proactiveinvestors.com.au/companies/news/126147/valirx-advancing-both-lead-compounds-126147.html Thu, 19 May 2016 10:44:00 +1000 https://www.proactiveinvestors.com.au/companies/news/126147/valirx-advancing-both-lead-compounds-126147.html ValiRx PLC readies for phase II clinical trial of lead cancer drug https://www.proactiveinvestors.com.au/companies/news/126130/valirx-plc-readies-for-phase-ii-clinical-trial-of-lead-cancer-drug-126130.html Thu, 19 May 2016 06:58:00 +1000 https://www.proactiveinvestors.com.au/companies/news/126130/valirx-plc-readies-for-phase-ii-clinical-trial-of-lead-cancer-drug-126130.html ValiRx joint venture awarded second US patent https://www.proactiveinvestors.com.au/companies/news/125404/valirx-joint-venture-awarded-second-us-patent-125404.html Fri, 29 Apr 2016 07:35:00 +1000 https://www.proactiveinvestors.com.au/companies/news/125404/valirx-joint-venture-awarded-second-us-patent-125404.html ValiRx PLC to present at leading US cancer conference https://www.proactiveinvestors.com.au/companies/news/124251/valirx-plc-to-present-at-leading-us-cancer-conference-124251.html Thu, 31 Mar 2016 07:24:00 +1100 https://www.proactiveinvestors.com.au/companies/news/124251/valirx-plc-to-present-at-leading-us-cancer-conference-124251.html ValiRx PLC tees up £4mln through convertible issue https://www.proactiveinvestors.com.au/companies/news/123900/valirx-plc-tees-up-4mln-through-convertible-issue-123900.html Mon, 21 Mar 2016 09:18:00 +1100 https://www.proactiveinvestors.com.au/companies/news/123900/valirx-plc-tees-up-4mln-through-convertible-issue-123900.html ValiRx PLC targets US institutions with new appointment https://www.proactiveinvestors.com.au/companies/news/123790/valirx-plc-targets-us-institutions-with-new-appointment-123790.html Thu, 17 Mar 2016 07:50:00 +1100 https://www.proactiveinvestors.com.au/companies/news/123790/valirx-plc-targets-us-institutions-with-new-appointment-123790.html ValiRx making progress on several fronts https://www.proactiveinvestors.com.au/companies/news/125774/valirx-making-progress-on-several-fronts-125774.html Thu, 10 Mar 2016 14:05:00 +1100 https://www.proactiveinvestors.com.au/companies/news/125774/valirx-making-progress-on-several-fronts-125774.html ValiRx raises £500,000 to progess cancer trial https://www.proactiveinvestors.com.au/companies/news/122642/valirx-raises-500000-to-progess-cancer-trial-122642.html Wed, 17 Feb 2016 13:29:00 +1100 https://www.proactiveinvestors.com.au/companies/news/122642/valirx-raises-500000-to-progess-cancer-trial-122642.html ValiRx trial group receives cancer treatment with no adverse effects https://www.proactiveinvestors.com.au/companies/news/122557/valirx-trial-group-receives-cancer-treatment-with-no-adverse-effects-122557.html Tue, 16 Feb 2016 07:55:00 +1100 https://www.proactiveinvestors.com.au/companies/news/122557/valirx-trial-group-receives-cancer-treatment-with-no-adverse-effects-122557.html ValiRx COO “extremely happy” with latest VAL201 trial results https://www.proactiveinvestors.com.au/companies/news/304637/valirx-coo-extremely-happy-with-latest-val201-trial-results-4637.html Wed, 10 Feb 2016 12:34:00 +1100 https://www.proactiveinvestors.com.au/companies/news/304637/valirx-coo-extremely-happy-with-latest-val201-trial-results-4637.html ValiRx looks at broadening lead drug to fertility problem https://www.proactiveinvestors.com.au/companies/news/122313/valirx-looks-at-broadening-lead-drug-to-fertility-problem-122313.html Tue, 09 Feb 2016 08:27:00 +1100 https://www.proactiveinvestors.com.au/companies/news/122313/valirx-looks-at-broadening-lead-drug-to-fertility-problem-122313.html ValiRx to expand prostate cancer trial after dose escalation https://www.proactiveinvestors.com.au/companies/news/119425/valirx-to-expand-prostate-cancer-trial-after-dose-escalation-119425.html Thu, 19 Nov 2015 12:19:00 +1100 https://www.proactiveinvestors.com.au/companies/news/119425/valirx-to-expand-prostate-cancer-trial-after-dose-escalation-119425.html ValiRx sets up in Boston to strengthen investor base https://www.proactiveinvestors.com.au/companies/news/117115/valirx-sets-up-in-boston-to-strengthen-investor-base-117115.html Thu, 05 Nov 2015 09:40:00 +1100 https://www.proactiveinvestors.com.au/companies/news/117115/valirx-sets-up-in-boston-to-strengthen-investor-base-117115.html ValiRx to collaborate on gene silencing tech https://www.proactiveinvestors.com.au/companies/news/116682/valirx-to-collaborate-on-gene-silencing-tech-116682.html Tue, 27 Oct 2015 08:04:00 +1100 https://www.proactiveinvestors.com.au/companies/news/116682/valirx-to-collaborate-on-gene-silencing-tech-116682.html ValiRx extends lymphoma biomarker patent protection to Japan https://www.proactiveinvestors.com.au/companies/news/111331/valirx-extends-lymphoma-biomarker-patent-protection-to-japan-111331.html Thu, 01 Oct 2015 06:39:00 +1000 https://www.proactiveinvestors.com.au/companies/news/111331/valirx-extends-lymphoma-biomarker-patent-protection-to-japan-111331.html ValiRx well placed to keep growth going https://www.proactiveinvestors.com.au/companies/news/110889/valirx-well-placed-to-keep-growth-going-110889.html Thu, 17 Sep 2015 11:26:00 +1000 https://www.proactiveinvestors.com.au/companies/news/110889/valirx-well-placed-to-keep-growth-going-110889.html ValiRx arranges £2.45mln finance for development work https://www.proactiveinvestors.com.au/companies/news/110839/valirx-arranges-245mln-finance-for-development-work-110839.html Wed, 16 Sep 2015 08:18:00 +1000 https://www.proactiveinvestors.com.au/companies/news/110839/valirx-arranges-245mln-finance-for-development-work-110839.html ValiRx signs collaboration deal with Leeds University https://www.proactiveinvestors.com.au/companies/news/109719/valirx-signs-collaboration-deal-with-leeds-university-109719.html Thu, 06 Aug 2015 07:11:00 +1000 https://www.proactiveinvestors.com.au/companies/news/109719/valirx-signs-collaboration-deal-with-leeds-university-109719.html ValiRx to up dosage in prostate cancer trial https://www.proactiveinvestors.com.au/companies/news/109184/valirx-to-up-dosage-in-prostate-cancer-trial-109184.html Tue, 21 Jul 2015 13:56:00 +1000 https://www.proactiveinvestors.com.au/companies/news/109184/valirx-to-up-dosage-in-prostate-cancer-trial-109184.html UPDATE - ValiRx to start clinical trial of lung cancer drug https://www.proactiveinvestors.com.au/companies/news/109050/update-valirx-to-start-clinical-trial-of-lung-cancer-drug-109050.html Thu, 16 Jul 2015 14:46:00 +1000 https://www.proactiveinvestors.com.au/companies/news/109050/update-valirx-to-start-clinical-trial-of-lung-cancer-drug-109050.html ValiSeek chief discusses upcoming clinical trials of lung cancer drug https://www.proactiveinvestors.com.au/companies/news/303951/valiseek-chief-discusses-upcoming-clinical-trials-of-lung-cancer-drug-3951.html Thu, 16 Jul 2015 14:37:00 +1000 https://www.proactiveinvestors.com.au/companies/news/303951/valiseek-chief-discusses-upcoming-clinical-trials-of-lung-cancer-drug-3951.html ValiRx encouraged by efficacy signs in cancer compound trial https://www.proactiveinvestors.com.au/companies/news/108366/valirx-encouraged-by-efficacy-signs-in-cancer-compound-trial-108366.html Thu, 25 Jun 2015 06:33:00 +1000 https://www.proactiveinvestors.com.au/companies/news/108366/valirx-encouraged-by-efficacy-signs-in-cancer-compound-trial-108366.html Valirx (LON:VAL) - One2One Investor Presentation 14th May 2015 https://www.proactiveinvestors.com.au/companies/news/303772/valirx-lonval-one2one-investor-presentation-14th-may-2015 Fri, 15 May 2015 09:43:00 +1000 https://www.proactiveinvestors.com.au/companies/news/303772/valirx-lonval-one2one-investor-presentation-14th-may-2015 ValiRx shares rocket on VAL401 US patent approval https://www.proactiveinvestors.com.au/companies/news/106780/valirx-shares-rocket-on-val401-us-patent-approval-106780.html Thu, 14 May 2015 16:04:00 +1000 https://www.proactiveinvestors.com.au/companies/news/106780/valirx-shares-rocket-on-val401-us-patent-approval-106780.html ValiRx talking to potential licence partners ‘all the time’ - chairman https://www.proactiveinvestors.com.au/companies/news/303771/valirx-talking-to-potential-licence-partners-all-the-time-chairman Thu, 14 May 2015 15:02:00 +1000 https://www.proactiveinvestors.com.au/companies/news/303771/valirx-talking-to-potential-licence-partners-all-the-time-chairman UPDATE - ValiRx joint-venture making progress https://www.proactiveinvestors.com.au/companies/news/106732/update-valirx-joint-venture-making-progress-106732.html Thu, 14 May 2015 10:05:00 +1000 https://www.proactiveinvestors.com.au/companies/news/106732/update-valirx-joint-venture-making-progress-106732.html UPDATE - ValiRx picks up first contract for gene technology platform https://www.proactiveinvestors.com.au/companies/news/68754/update-valirx-picks-up-first-contract-for-gene-technology-platform--80070.html Thu, 07 May 2015 11:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/68754/update-valirx-picks-up-first-contract-for-gene-technology-platform--80070.html ValiRx eyes international partnerships https://www.proactiveinvestors.com.au/companies/news/68568/valirx-eyes-international-partnerships--79862.html Thu, 30 Apr 2015 09:58:00 +1000 https://www.proactiveinvestors.com.au/companies/news/68568/valirx-eyes-international-partnerships--79862.html ValiRx unveils plans to reduce share capital https://www.proactiveinvestors.com.au/companies/news/68294/valirx-unveils-plans-to-reduce-share-capital-79563.html Wed, 22 Apr 2015 08:45:00 +1000 https://www.proactiveinvestors.com.au/companies/news/68294/valirx-unveils-plans-to-reduce-share-capital-79563.html ValiRx optimistic over first clinical trial https://www.proactiveinvestors.com.au/companies/news/68090/valirx-optimistic-over-first-clinical-trial--79346.html Thu, 16 Apr 2015 08:46:00 +1000 https://www.proactiveinvestors.com.au/companies/news/68090/valirx-optimistic-over-first-clinical-trial--79346.html ValiRx makes milestone payment as lead compound progresses https://www.proactiveinvestors.com.au/companies/news/67139/valirx-makes-milestone-payment-as-lead-compound-progresses-78319.html Tue, 17 Mar 2015 06:30:00 +1100 https://www.proactiveinvestors.com.au/companies/news/67139/valirx-makes-milestone-payment-as-lead-compound-progresses-78319.html VailRx raises another £800,000 to fund clinical work https://www.proactiveinvestors.com.au/companies/news/66853/vailrx-raises-another-800000-to-fund-clinical-work-77994.html Fri, 06 Mar 2015 06:36:00 +1100 https://www.proactiveinvestors.com.au/companies/news/66853/vailrx-raises-another-800000-to-fund-clinical-work-77994.html ValiRx awarded endometriosis patent in UK for lead compound https://www.proactiveinvestors.com.au/companies/news/66575/valirx-awarded-endometriosis-patent-in-uk-for-lead-compound-77687.html Thu, 26 Feb 2015 07:04:00 +1100 https://www.proactiveinvestors.com.au/companies/news/66575/valirx-awarded-endometriosis-patent-in-uk-for-lead-compound-77687.html ValiRx solid tumour treatment well tolerated in trial https://www.proactiveinvestors.com.au/companies/news/66489/valirx-solid-tumour-treatment-well-tolerated-in-trial-77591.html Tue, 24 Feb 2015 07:25:00 +1100 https://www.proactiveinvestors.com.au/companies/news/66489/valirx-solid-tumour-treatment-well-tolerated-in-trial-77591.html ValiRx gets patent for lymphoma screening test https://www.proactiveinvestors.com.au/companies/news/66113/valirx-gets-patent-for-lymphoma-screening-test-77173.html Wed, 11 Feb 2015 07:32:00 +1100 https://www.proactiveinvestors.com.au/companies/news/66113/valirx-gets-patent-for-lymphoma-screening-test-77173.html ValiRx strengthens biomarker expertise with technology buy https://www.proactiveinvestors.com.au/companies/news/65942/valirx-strengthens-biomarker-expertise-with-technology-buy-76983.html Thu, 05 Feb 2015 07:04:00 +1100 https://www.proactiveinvestors.com.au/companies/news/65942/valirx-strengthens-biomarker-expertise-with-technology-buy-76983.html ValiRx COO Morris highlights ‘very important year’ for company https://www.proactiveinvestors.com.au/companies/news/302970/valirx-coo-morris-highlights-very-important-year-for-company-3406.html Thu, 15 Jan 2015 13:28:00 +1100 https://www.proactiveinvestors.com.au/companies/news/302970/valirx-coo-morris-highlights-very-important-year-for-company-3406.html ValiRx making progress on two fronts; first data from lead compound expected this quarter https://www.proactiveinvestors.com.au/companies/news/65284/valirx-making-progress-on-two-fronts-first-data-from-lead-compound-expected-this-quarter-76232.html Thu, 15 Jan 2015 06:54:00 +1100 https://www.proactiveinvestors.com.au/companies/news/65284/valirx-making-progress-on-two-fronts-first-data-from-lead-compound-expected-this-quarter-76232.html ValiRx delighted with toxicology results at joint venture https://www.proactiveinvestors.com.au/companies/news/64218/valirx-delighted-with-toxicology-results-at-joint-venture--75035.html Thu, 04 Dec 2014 07:23:00 +1100 https://www.proactiveinvestors.com.au/companies/news/64218/valirx-delighted-with-toxicology-results-at-joint-venture--75035.html ValiRx expects first results from prostate drug trial in first quarter of next year https://www.proactiveinvestors.com.au/companies/news/63956/valirx-expects-first-results-from-prostate-drug-trial-in-first-quarter-of-next-year-74737.html Wed, 26 Nov 2014 06:59:00 +1100 https://www.proactiveinvestors.com.au/companies/news/63956/valirx-expects-first-results-from-prostate-drug-trial-in-first-quarter-of-next-year-74737.html ValiRx cements ties with Germany's largest biomedical institute to develop unique technology https://www.proactiveinvestors.com.au/companies/news/63586/valirx-cements-ties-with-germanys-largest-biomedical-institute-to-develop-unique-technology-74299.html Thu, 13 Nov 2014 06:36:00 +1100 https://www.proactiveinvestors.com.au/companies/news/63586/valirx-cements-ties-with-germanys-largest-biomedical-institute-to-develop-unique-technology-74299.html ValiRx shares lifted as VAL201 trial progresses on schedule https://www.proactiveinvestors.com.au/companies/news/63273/valirx-shares-lifted-as-val201-trial-progresses-on-schedule-73927.html Mon, 03 Nov 2014 14:33:00 +1100 https://www.proactiveinvestors.com.au/companies/news/63273/valirx-shares-lifted-as-val201-trial-progresses-on-schedule-73927.html ValiRx CEO on upcoming trial https://www.proactiveinvestors.com.au/companies/news/302777/valirx-ceo-on-upcoming-trial-3173.html Thu, 16 Oct 2014 13:46:00 +1100 https://www.proactiveinvestors.com.au/companies/news/302777/valirx-ceo-on-upcoming-trial-3173.html ValiRx to start patient recruitment for lead compound trial https://www.proactiveinvestors.com.au/companies/news/62765/valirx-to-start-patient-recruitment-for-lead-compound-trial-73329.html Tue, 14 Oct 2014 07:05:00 +1100 https://www.proactiveinvestors.com.au/companies/news/62765/valirx-to-start-patient-recruitment-for-lead-compound-trial-73329.html ValiRx's equity swap agreement with Yorkville comes to an end https://www.proactiveinvestors.com.au/companies/news/62522/valirxs-equity-swap-agreement-with-yorkville-comes-to-an-end-73054.html Wed, 08 Oct 2014 15:53:00 +1100 https://www.proactiveinvestors.com.au/companies/news/62522/valirxs-equity-swap-agreement-with-yorkville-comes-to-an-end-73054.html ValiRx encouraged by efficacy data from lung cancer JV https://www.proactiveinvestors.com.au/companies/news/61334/valirx-encouraged-by-efficacy-data-from-lung-cancer-jv-71796.html ValiRx’s joint venture with Tangent Reprofiling, ValiSeek, has received a boost from the preclinical efficacy studies on its lead lung cancer treatment.

]]>
Tue, 02 Sep 2014 12:59:00 +1000 https://www.proactiveinvestors.com.au/companies/news/61334/valirx-encouraged-by-efficacy-data-from-lung-cancer-jv-71796.html
ValiRx's interims show cash burn is not a worry, broker affirms https://www.proactiveinvestors.com.au/companies/news/61067/valirxs-interims-show-cash-burn-is-not-a-worry-broker-affirms-71513.html Thu, 21 Aug 2014 10:24:00 +1000 https://www.proactiveinvestors.com.au/companies/news/61067/valirxs-interims-show-cash-burn-is-not-a-worry-broker-affirms-71513.html ValiRx happy with first half progress https://www.proactiveinvestors.com.au/companies/news/60983/valirx-happy-with-first-half-progress-71424.html Tue, 19 Aug 2014 07:37:00 +1000 https://www.proactiveinvestors.com.au/companies/news/60983/valirx-happy-with-first-half-progress-71424.html |UPDATE - ValiRx gets MHRA approval for phase I/II cancer trial https://www.proactiveinvestors.com.au/companies/news/60543/update-valirx-gets-mhra-approval-for-phase-iii-cancer-trial-70954.html Mon, 04 Aug 2014 09:23:00 +1000 https://www.proactiveinvestors.com.au/companies/news/60543/update-valirx-gets-mhra-approval-for-phase-iii-cancer-trial-70954.html ValiRx lead treatment moves to human stage cancer trial https://www.proactiveinvestors.com.au/companies/news/58952/valirx-lead-treatment-moves-to-human-stage-cancer-trial-69288.html Tue, 10 Jun 2014 06:58:00 +1000 https://www.proactiveinvestors.com.au/companies/news/58952/valirx-lead-treatment-moves-to-human-stage-cancer-trial-69288.html ValiRx pleased with new joint venture's early progress https://www.proactiveinvestors.com.au/companies/news/58259/valirx-pleased-with-new-joint-ventures-early-progress-68533.html Thu, 15 May 2014 06:47:00 +1000 https://www.proactiveinvestors.com.au/companies/news/58259/valirx-pleased-with-new-joint-ventures-early-progress-68533.html ValiRx gets Japanese patent approval for NAV3 biomarker https://www.proactiveinvestors.com.au/companies/news/57856/valirx-gets-japanese-patent-approval-for-nav3-biomarker-68114.html Thu, 01 May 2014 06:19:00 +1000 https://www.proactiveinvestors.com.au/companies/news/57856/valirx-gets-japanese-patent-approval-for-nav3-biomarker-68114.html Upgrade hints at ValiRx's significant potential https://www.proactiveinvestors.com.au/companies/news/57398/upgrade-hints-at-valirxs-significant-potential--67632.html The City broker Daniel Stewart has lifted its valuation on drug developer ValiRx following the recent acquisition of VAL401, a clinical-stage potential treatment for lung cancer.

]]>
Mon, 14 Apr 2014 11:29:00 +1000 https://www.proactiveinvestors.com.au/companies/news/57398/upgrade-hints-at-valirxs-significant-potential--67632.html
Valirx One2One Investor Presentation April 10th 2014 https://www.proactiveinvestors.com.au/companies/news/302373/ Fri, 11 Apr 2014 12:56:00 +1000 https://www.proactiveinvestors.com.au/companies/news/302373/ UPDATE - ValiRx sets up joint venture to advance lung cancer drug https://www.proactiveinvestors.com.au/companies/news/57218/update-valirx-sets-up-joint-venture-to-advance-lung-cancer-drug-67445.html Tue, 08 Apr 2014 13:50:00 +1000 https://www.proactiveinvestors.com.au/companies/news/57218/update-valirx-sets-up-joint-venture-to-advance-lung-cancer-drug-67445.html ValiRx sets up joint venture to advance lung cancer drug https://www.proactiveinvestors.com.au/companies/news/57219/valirx-sets-up-joint-venture-to-advance-lung-cancer-drug-67446.html Tue, 08 Apr 2014 06:44:00 +1000 https://www.proactiveinvestors.com.au/companies/news/57219/valirx-sets-up-joint-venture-to-advance-lung-cancer-drug-67446.html ValiRx, e-Therapeutics, Oxford Pharmascience and Action Hotels to present next week https://www.proactiveinvestors.com.au/companies/news/57148/valirx-e-therapeutics-oxford-pharmascience-and-action-hotels-to-present-next-week-67363.html Next week's Proactive forum promises to be a dynamic evening as it showcases some of the most exciting non-resource companies, which are hot on the market right now.

]]>
Fri, 04 Apr 2014 15:30:00 +1100 https://www.proactiveinvestors.com.au/companies/news/57148/valirx-e-therapeutics-oxford-pharmascience-and-action-hotels-to-present-next-week-67363.html
Q&A: ValiRx looks forward to clinical trials https://www.proactiveinvestors.com.au/companies/news/57022/qa-valirx-looks-forward-to-clinical-trials-67228.html Proactive Investors (PI) interviewed the management of the cancer drug treatment developer to find out about future plans.

]]>
Tue, 01 Apr 2014 12:20:00 +1100 https://www.proactiveinvestors.com.au/companies/news/57022/qa-valirx-looks-forward-to-clinical-trials-67228.html
ValiRx to carry out further stability and sterility work on VAL201 https://www.proactiveinvestors.com.au/companies/news/57002/valirx-to-carry-out-further-stability-and-sterility-work-on-val201-67208.html Tue, 01 Apr 2014 06:46:00 +1100 https://www.proactiveinvestors.com.au/companies/news/57002/valirx-to-carry-out-further-stability-and-sterility-work-on-val201-67208.html ValiRx says annual results show the company is 'making progress' https://www.proactiveinvestors.com.au/companies/news/302333/valirx-says-annual-results-show-the-company-is-making-progress--2333.html Wed, 26 Mar 2014 15:35:00 +1100 https://www.proactiveinvestors.com.au/companies/news/302333/valirx-says-annual-results-show-the-company-is-making-progress--2333.html ValiRx has secure funding platform to drive VAL201 process https://www.proactiveinvestors.com.au/companies/news/56624/valirx-has-secure-funding-platform-to-drive-val201-process-66815.html Wed, 19 Mar 2014 07:12:00 +1100 https://www.proactiveinvestors.com.au/companies/news/56624/valirx-has-secure-funding-platform-to-drive-val201-process-66815.html ValirX gets new European grant for cancer screening biomarker https://www.proactiveinvestors.com.au/companies/news/55830/valirx-gets-new-european-grant-for-cancer-screening-biomarker-65961.html Thu, 20 Feb 2014 06:10:00 +1100 https://www.proactiveinvestors.com.au/companies/news/55830/valirx-gets-new-european-grant-for-cancer-screening-biomarker-65961.html ValiRx's stake sale provides cash run-way, says Daniel Stewart https://www.proactiveinvestors.com.au/companies/news/55397/valirxs-stake-sale-provides-cash-run-way-says-daniel-stewart-65505.html Tue, 04 Feb 2014 12:08:00 +1100 https://www.proactiveinvestors.com.au/companies/news/55397/valirxs-stake-sale-provides-cash-run-way-says-daniel-stewart-65505.html ValiRx cashes in on VolitionRx stake https://www.proactiveinvestors.com.au/companies/news/55301/valirx-cashes-in-on-volitionrx-stake-65403.html Fri, 31 Jan 2014 13:47:00 +1100 https://www.proactiveinvestors.com.au/companies/news/55301/valirx-cashes-in-on-volitionrx-stake-65403.html ValiRx raises up to £2.9mln as development pace quickens https://www.proactiveinvestors.com.au/companies/news/54440/valirx-raises-up-to-29mln-as-development-pace-quickens-64474.html Fri, 27 Dec 2013 06:30:00 +1100 https://www.proactiveinvestors.com.au/companies/news/54440/valirx-raises-up-to-29mln-as-development-pace-quickens-64474.html ValiRx cancer screening method receives patent protection in Australia https://www.proactiveinvestors.com.au/companies/news/53890/valirx-cancer-screening-method-receives-patent-protection-in-australia-63908.html Thu, 05 Dec 2013 06:58:00 +1100 https://www.proactiveinvestors.com.au/companies/news/53890/valirx-cancer-screening-method-receives-patent-protection-in-australia-63908.html ValiRx reports "encouraging" news on lead compound https://www.proactiveinvestors.com.au/companies/news/53680/valirx-reports-encouraging-news-on-lead-compound-63662.html There was encouraging news from the laboratory for ValiRx and its lead compound, VAL201 for cancer.

]]>
Thu, 28 Nov 2013 06:35:00 +1100 https://www.proactiveinvestors.com.au/companies/news/53680/valirx-reports-encouraging-news-on-lead-compound-63662.html
ValiRx raises £1mln in placing https://www.proactiveinvestors.com.au/companies/news/53303/valirx-raises-1mln-in-placing-63268.html Fri, 15 Nov 2013 06:14:00 +1100 https://www.proactiveinvestors.com.au/companies/news/53303/valirx-raises-1mln-in-placing-63268.html ValiRx shares surge as targets expanded Phase 1b trial for lead compound https://www.proactiveinvestors.com.au/companies/news/52633/valirx-shares-surge-as-targets-expanded-phase-1b-trial-for-lead-compound-62509.html Shares in drug developer ValiRx surged Thursday after the firm got the green light for a plan to carry out an expanded Phase 1b trial for lead compound VAL201

]]>
Thu, 24 Oct 2013 16:34:00 +1100 https://www.proactiveinvestors.com.au/companies/news/52633/valirx-shares-surge-as-targets-expanded-phase-1b-trial-for-lead-compound-62509.html
ValiRx expects rapid results from first-in-man VAL201 trial https://www.proactiveinvestors.com.au/companies/news/51977/valirx-expects-rapid-results-from-first-in-man-val201-trial-61769.html Thu, 03 Oct 2013 06:31:00 +1000 https://www.proactiveinvestors.com.au/companies/news/51977/valirx-expects-rapid-results-from-first-in-man-val201-trial-61769.html ValiRx interims reveal a period of 'encouraging progress' https://www.proactiveinvestors.com.au/companies/news/51093/valirx-interims-reveal-a-period-of-encouraging-progress-60771.html Life sciences group ValiRx has confirmed it expects to release results from the clinical trial of its lead drug in December. VAL 201 is currently undergoing first-in-man studies on cancer patients - illustrating the strides the group has made in the first half of the year.

]]>
Thu, 05 Sep 2013 07:08:00 +1000 https://www.proactiveinvestors.com.au/companies/news/51093/valirx-interims-reveal-a-period-of-encouraging-progress-60771.html
ValiRx's €1.6mln Eurostars grant provides endorsement of its technology https://www.proactiveinvestors.com.au/companies/news/50464/valirxs-16mln-eurostars-grant-provides-endorsement-of-its-technology-60061.html ValiRx Plc said it and Pharmatest Services will share a new Eurostars grant worth up to €1.6mln that will fund pre-clinical studies on its drug candidate VAL101, which regulates rebellious genes. The cash will also be used for finding additional compounds from the company’s GeneICE platform “directed at known cancer targets”.

]]>
Thu, 15 Aug 2013 07:02:00 +1000 https://www.proactiveinvestors.com.au/companies/news/50464/valirxs-16mln-eurostars-grant-provides-endorsement-of-its-technology-60061.html
ValiRx's lead compound trial progresses on schedule https://www.proactiveinvestors.com.au/companies/news/50033/valirxs-lead-compound-trial-progresses-on-schedule-59567.html Wed, 31 Jul 2013 08:19:00 +1000 https://www.proactiveinvestors.com.au/companies/news/50033/valirxs-lead-compound-trial-progresses-on-schedule-59567.html ValiRx One2One Forum Presentation 26th June 2013 https://www.proactiveinvestors.com.au/companies/news/301843/valirx-one2one-forum-presentation-26th-june-2013-2067.html Wed, 26 Jun 2013 20:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/301843/valirx-one2one-forum-presentation-26th-june-2013-2067.html Showcasing Britain's Talent- Proactive One2One forums come to London & Manchester https://www.proactiveinvestors.com.au/companies/news/48894/showcasing-britains-talent-proactive-one2one-forums-come-to-london-manchester-58264.html ‘London to Manchester’ sounds like the title to a biography of footballer Robin van Persie, but is, in fact, a description of Proactive Investors’ exciting events schedule in the final week of June.

]]>
Fri, 21 Jun 2013 17:50:00 +1000 https://www.proactiveinvestors.com.au/companies/news/48894/showcasing-britains-talent-proactive-one2one-forums-come-to-london-manchester-58264.html
UPDATE- ValiRx agrees details of cancer study https://www.proactiveinvestors.com.au/companies/news/48633/update-valirx-agrees-details-of-cancer-study--57958.html ValiRx has agreed an expanded and adaptive protocol for its first-in-man studies on VAL 201, its drug candidate being developed for prostate cancer. This simply means the early-stage study has been tweaked to allow the compound to move more efficiently to the crucial phase II clinical trial stage. 

]]>
Thu, 13 Jun 2013 14:22:00 +1000 https://www.proactiveinvestors.com.au/companies/news/48633/update-valirx-agrees-details-of-cancer-study--57958.html
ValiRx looks to social impact market as becomes founder member of new exchange https://www.proactiveinvestors.com.au/companies/news/48433/valirx-looks-to-social-impact-market-as-becomes-founder-member-of-new-exchange-57722.html Thu, 06 Jun 2013 09:29:00 +1000 https://www.proactiveinvestors.com.au/companies/news/48433/valirx-looks-to-social-impact-market-as-becomes-founder-member-of-new-exchange-57722.html ValiRx well-positioned to feed Big Pharma https://www.proactiveinvestors.com.au/companies/news/301744/valirx-well-positioned-to-feed-big-pharma--1945.html Fri, 26 Apr 2013 10:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/301744/valirx-well-positioned-to-feed-big-pharma--1945.html ValiRx granted patent in Australia for top compound https://www.proactiveinvestors.com.au/companies/news/47129/valirx-granted-patent-in-australia-for-top-compound-56198.html Thu, 25 Apr 2013 06:54:00 +1000 https://www.proactiveinvestors.com.au/companies/news/47129/valirx-granted-patent-in-australia-for-top-compound-56198.html ValiRx taking huge strides in developing breakthrough cancer drug https://www.proactiveinvestors.com.au/companies/news/46957/valirx-taking-huge-strides-in-developing-breakthrough-cancer-drug-55993.html ValiRx is an interesting example of where the changing industry backdrop may eventually aid the smaller company. However, talk of deals with industry players is a little premature for the group, whose challenge currently is to take its lead drug candidate, VAL201 for cancer, from the pre-clinical phase into first-in-man trials.

]]>
Fri, 19 Apr 2013 08:10:00 +1000 https://www.proactiveinvestors.com.au/companies/news/46957/valirx-taking-huge-strides-in-developing-breakthrough-cancer-drug-55993.html
ValiRx given international showcase at prestigious American cancer event https://www.proactiveinvestors.com.au/companies/news/46380/valirx-given-international-showcase-at-prestigious-american-cancer-event-55333.html The drug developer ValiRx has been asked to give a presentations at the prestigious American Association for Cancer Research Conference in Washington starting this Saturday. Attended by 17,000 oncology experts, this is by far the largest of a series of events the company is using to engage with the scientific and investor communities.

]]>
Tue, 02 Apr 2013 06:32:00 +1100 https://www.proactiveinvestors.com.au/companies/news/46380/valirx-given-international-showcase-at-prestigious-american-cancer-event-55333.html
ValiRx hopes to achieve some "momentous milestones" https://www.proactiveinvestors.com.au/companies/news/46327/valirx-hopes-to-achieve-some-momentous-milestones--55265.html Thu, 28 Mar 2013 06:58:00 +1100 https://www.proactiveinvestors.com.au/companies/news/46327/valirx-hopes-to-achieve-some-momentous-milestones--55265.html ValiRx appoints chief commercial officer https://www.proactiveinvestors.com.au/companies/news/45222/valirx-appoints-chief-commercial-officer-53948.html Thu, 21 Feb 2013 06:53:00 +1100 https://www.proactiveinvestors.com.au/companies/news/45222/valirx-appoints-chief-commercial-officer-53948.html ValiRx appoints experienced medical monitoring officer for VAL201 https://www.proactiveinvestors.com.au/companies/news/44222/valirx-appoints-experienced-medical-monitoring-officer-for-val201-52762.html Wed, 23 Jan 2013 06:59:00 +1100 https://www.proactiveinvestors.com.au/companies/news/44222/valirx-appoints-experienced-medical-monitoring-officer-for-val201-52762.html ValiRx gears up for phase I clinical trials after £2 mln cash injection https://www.proactiveinvestors.com.au/companies/news/42452/valirx-gears-up-for-phase-i-clinical-trials-after-2-mln-cash-injection-50666.html Life sciences group ValiRx said the recent £2.03 mln cash call allows it to take VAL201 through first human clinical trials. It is hoped this potentially breakthrough treatment for cancer can tackle a number of strands of the disease including breast, ovarian and prostate forms.

]]>
Thu, 22 Nov 2012 06:23:00 +1100 https://www.proactiveinvestors.com.au/companies/news/42452/valirx-gears-up-for-phase-i-clinical-trials-after-2-mln-cash-injection-50666.html
ValirX to raise £2.03 million to take VAL201 through first clinical trial https://www.proactiveinvestors.com.au/companies/news/41788/valirx-to-raise-203-million-to-take-val201-through-first-clinical-trial-49827.html Thu, 01 Nov 2012 14:16:00 +1100 https://www.proactiveinvestors.com.au/companies/news/41788/valirx-to-raise-203-million-to-take-val201-through-first-clinical-trial-49827.html ValiRx deal allows co to concentrate on drug development https://www.proactiveinvestors.com.au/companies/news/41100/valirx-deal-allows-co-to-concentrate-on-drug-development-49007.html ValiRx has sealed a distribution deal for its SELFCheck screening products that leaves it free to concentrate on the development VAL 201 and VAL 101, two exciting drug candidate that target cancer. 

]]>
Thu, 11 Oct 2012 06:24:00 +1100 https://www.proactiveinvestors.com.au/companies/news/41100/valirx-deal-allows-co-to-concentrate-on-drug-development-49007.html
ValiRx mulls phase one trial for lead compound without partner https://www.proactiveinvestors.com.au/companies/news/40448/valirx-mulls-phase-one-trial-for-lead-compound-without-partner-48242.html Thu, 20 Sep 2012 06:34:00 +1000 https://www.proactiveinvestors.com.au/companies/news/40448/valirx-mulls-phase-one-trial-for-lead-compound-without-partner-48242.html ValiRx's lead compound has impact in breast cancer study https://www.proactiveinvestors.com.au/companies/news/40008/valirxs-lead-compound-has-impact-in-breast-cancer-study-47732.html Shares rise by 10 per cent as latest research shows VAL201 has a positive effect in the estrogen pathway in women.

]]>
Thu, 06 Sep 2012 07:04:00 +1000 https://www.proactiveinvestors.com.au/companies/news/40008/valirxs-lead-compound-has-impact-in-breast-cancer-study-47732.html
ValiRx technology has potential for "wide range" of treatments https://www.proactiveinvestors.com.au/companies/news/38770/valirx-technology-has-potential-for-wide-range-of-treatments-46332.html Thu, 02 Aug 2012 07:04:00 +1000 https://www.proactiveinvestors.com.au/companies/news/38770/valirx-technology-has-potential-for-wide-range-of-treatments-46332.html Mellon looks at potential new medicines which could transform society - Pt 2 https://www.proactiveinvestors.com.au/companies/news/36530/mellon-looks-at-potential-new-medicines-which-could-transform-society-pt-2-43672.html Here, in the second installment of a three-part interview, we quiz Jim Mellon on the potential new medicines that have the capacity to transform society, and discuss how this might happen.

 

]]>
Mon, 04 Jun 2012 09:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/36530/mellon-looks-at-potential-new-medicines-which-could-transform-society-pt-2-43672.html
ValiRx: shares rise 40% on new study of VAL201 https://www.proactiveinvestors.com.au/companies/news/301178/valirx-shares-rise-40-on-new-study-of-val201-1188.html Fri, 01 Jun 2012 15:58:00 +1000 https://www.proactiveinvestors.com.au/companies/news/301178/valirx-shares-rise-40-on-new-study-of-val201-1188.html ValiRx shares soar as reveals highly encouraging cancer study results https://www.proactiveinvestors.com.au/companies/news/36384/valirx-shares-soar-as-reveals-highly-encouraging-cancer-study-results--43477.html The ValiRix share price has shot up on the back of today’s findings, which represent a major step forward, as they independently confirm and build on earlier studies carried out by ValiRx.

]]>
Tue, 29 May 2012 12:34:00 +1000 https://www.proactiveinvestors.com.au/companies/news/36384/valirx-shares-soar-as-reveals-highly-encouraging-cancer-study-results--43477.html
ValiRx reveals highly encouraging cancer study results https://www.proactiveinvestors.com.au/companies/news/36357/valirx-reveals-highly-encouraging-cancer-study-results--43451.html Today’s findings represent a major step forward as they independently confirm and build on earlier studies carried out by ValiRx.

]]>
Tue, 29 May 2012 06:10:00 +1000 https://www.proactiveinvestors.com.au/companies/news/36357/valirx-reveals-highly-encouraging-cancer-study-results--43451.html
ValiRx wins new US patent for cancer screening gene biomarker https://www.proactiveinvestors.com.au/companies/news/35815/valirx-wins-new-us-patent-for-cancer-screening-gene-biomarker-42803.html Tue, 15 May 2012 06:31:00 +1000 https://www.proactiveinvestors.com.au/companies/news/35815/valirx-wins-new-us-patent-for-cancer-screening-gene-biomarker-42803.html ValiRx full year revenues jump 157pct https://www.proactiveinvestors.com.au/companies/news/35210/valirx-full-year-revenues-jump-157pct-42027.html Fri, 27 Apr 2012 07:54:00 +1000 https://www.proactiveinvestors.com.au/companies/news/35210/valirx-full-year-revenues-jump-157pct-42027.html ValiRx raises £900,000 to advance pipeline https://www.proactiveinvestors.com.au/companies/news/34405/ValiRx-raises-%C2%A3900-000-to-advance-pipeline-41009.html Mon, 02 Apr 2012 07:48:00 +1000 https://www.proactiveinvestors.com.au/companies/news/34405/ValiRx-raises-%C2%A3900-000-to-advance-pipeline-41009.html ValiRx CEO says the company is now at an exciting pre-clinical stage https://www.proactiveinvestors.com.au/companies/news/300735/valirx-ceo-says-the-company-is-now-at-an-exciting-pre-clinical-stage-1098.html Fri, 30 Mar 2012 12:46:00 +1100 https://www.proactiveinvestors.com.au/companies/news/300735/valirx-ceo-says-the-company-is-now-at-an-exciting-pre-clinical-stage-1098.html ValiRx One2One Investor Presentation - 29th March 2012 https://www.proactiveinvestors.com.au/companies/news/300724/valirx-one2one-investor-presentation-29th-march-2012-1093.html Thu, 29 Mar 2012 08:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/300724/valirx-one2one-investor-presentation-29th-march-2012-1093.html ValiRx collaboration points the way to clinical trials https://www.proactiveinvestors.com.au/companies/news/34294/valirx-collaboration-points-the-way-to-clinical-trials-40877.html ValiRx Plc has completed what it calls a material transfer agreement which will see the Institut Paoli & Calmettes in Marseille carry out translational and developmental studies on the company’s potential treatment for prostate cancer.

]]>
Thu, 29 Mar 2012 06:29:00 +1100 https://www.proactiveinvestors.com.au/companies/news/34294/valirx-collaboration-points-the-way-to-clinical-trials-40877.html
ValiRx's VAL201 may have important role to play in prostate cancer treatment, says medical journal https://www.proactiveinvestors.com.au/companies/news/33523/valirxs-val201-may-have-important-role-to-play-in-prostate-cancer-treatment-says-medical-journal-39954.html Thu, 08 Mar 2012 06:14:00 +1100 https://www.proactiveinvestors.com.au/companies/news/33523/valirxs-val201-may-have-important-role-to-play-in-prostate-cancer-treatment-says-medical-journal-39954.html ValiRx sets up scientific advisory board to support move to clinical trials https://www.proactiveinvestors.com.au/companies/news/32716/valirx-sets-up-scientific-advisory-board-to-support-move-to-clinical-trials--38951.html Tue, 14 Feb 2012 06:56:00 +1100 https://www.proactiveinvestors.com.au/companies/news/32716/valirx-sets-up-scientific-advisory-board-to-support-move-to-clinical-trials--38951.html ValiRx shares soar on skin cancer testing patent in Europe https://www.proactiveinvestors.com.au/companies/news/32346/valirx-shares-soar-on-skin-cancer-testing-patent-in-europe-38516.html Landing the patent means that ValiRx can start marketing the product to the oncology research industry and fellow drug developers, while planning a larger product launch into the wider market.

]]>
Thu, 02 Feb 2012 13:55:00 +1100 https://www.proactiveinvestors.com.au/companies/news/32346/valirx-shares-soar-on-skin-cancer-testing-patent-in-europe-38516.html
ValiRx shares soar as cancer test gets EU patent https://www.proactiveinvestors.com.au/companies/news/32326/valirx-shares-soar-as-cancer-test-gets-eu-patent--38494.html Shares in life science firm ValiRx shot up around 35 per cent in early deals after it was granted a new European patents for a cancer screening product. The test enables the detection of cancer cells when tumour development is about to start.

]]>
Thu, 02 Feb 2012 07:40:00 +1100 https://www.proactiveinvestors.com.au/companies/news/32326/valirx-shares-soar-as-cancer-test-gets-eu-patent--38494.html
ValiRx inks biomarker deal https://www.proactiveinvestors.com.au/companies/news/31360/valirx-inks-biomarker-deal--37485.html  

ValiRx said this morning it is acquiring the biomarkers arm of Finnish firm Pharmatest in a deal that values the business at £137,000. The AIM-listed drug developer is paying around £62,000 in cash (€75,000) and will issue Pharmatest with 15 million shares worth just over £75,000 at today’s prices. Pharmatest may also be entitled to royalty payments.

 

]]>
Thu, 05 Jan 2012 06:38:00 +1100 https://www.proactiveinvestors.com.au/companies/news/31360/valirx-inks-biomarker-deal--37485.html
ValiRx has its price target increased by broker Hybridan https://www.proactiveinvestors.com.au/companies/news/31056/valirx-has-its-price-target-increased-by-broker-hybridan-37128.html Mon, 19 Dec 2011 14:30:00 +1100 https://www.proactiveinvestors.com.au/companies/news/31056/valirx-has-its-price-target-increased-by-broker-hybridan-37128.html ValiRx gives upbeat update on VAL 101 https://www.proactiveinvestors.com.au/companies/news/30946/valirx-gives-upbeat-update-on-val-101-37006.html Thu, 15 Dec 2011 07:05:00 +1100 https://www.proactiveinvestors.com.au/companies/news/30946/valirx-gives-upbeat-update-on-val-101-37006.html ValiRx launches self-testing products in East Midlands region https://www.proactiveinvestors.com.au/companies/news/30164/valirx-launches-self-testing-products-in-east-midlands-region-36062.html Thu, 24 Nov 2011 07:04:00 +1100 https://www.proactiveinvestors.com.au/companies/news/30164/valirx-launches-self-testing-products-in-east-midlands-region-36062.html ValiRx shares jump in early trading after patent filing https://www.proactiveinvestors.com.au/companies/news/29400/valirx-shares-jump-in-early-trading-after-patent-filing-35154.html Thu, 03 Nov 2011 07:27:00 +1100 https://www.proactiveinvestors.com.au/companies/news/29400/valirx-shares-jump-in-early-trading-after-patent-filing-35154.html ValiRx to present therapeutic programmes data at Biopartnering Europe conference https://www.proactiveinvestors.com.au/companies/news/28228/valirx-to-present-therapeutic-programmes-data-at-biopartnering-europe-conference-33730.html Thu, 29 Sep 2011 07:11:00 +1000 https://www.proactiveinvestors.com.au/companies/news/28228/valirx-to-present-therapeutic-programmes-data-at-biopartnering-europe-conference-33730.html ValiRx to get US$1.1 million of shares in US-quoted VolitionRx https://www.proactiveinvestors.com.au/companies/news/28124/valirx-to-get-us11-million-of-shares-in-us-quoted-volitionrx-33598.html Tue, 27 Sep 2011 06:33:00 +1000 https://www.proactiveinvestors.com.au/companies/news/28124/valirx-to-get-us11-million-of-shares-in-us-quoted-volitionrx-33598.html ValiRx made good progress in first half as revenues soared https://www.proactiveinvestors.com.au/companies/news/27999/valirx-made-good-progress-in-first-half-as-revenues-soared-33457.html Thu, 22 Sep 2011 06:55:00 +1000 https://www.proactiveinvestors.com.au/companies/news/27999/valirx-made-good-progress-in-first-half-as-revenues-soared-33457.html ValiRx teams up with Physiomics to accelerate the development of anti-cancer compound https://www.proactiveinvestors.com.au/companies/news/27661/ValiRx-teams-up-with-Physiomics-to-accelerate-the-development-of-anti-cancer-compound-33038.html Tue, 13 Sep 2011 07:18:00 +1000 https://www.proactiveinvestors.com.au/companies/news/27661/ValiRx-teams-up-with-Physiomics-to-accelerate-the-development-of-anti-cancer-compound-33038.html ValiRx signs SELFCheck distribution deal in Nordic region https://www.proactiveinvestors.com.au/companies/news/27522/valirx-signs-selfcheck-distribution-deal-in-nordic-region-32870.html Thu, 08 Sep 2011 08:46:00 +1000 https://www.proactiveinvestors.com.au/companies/news/27522/valirx-signs-selfcheck-distribution-deal-in-nordic-region-32870.html ValiRx buys out Finnish subsidiary https://www.proactiveinvestors.com.au/companies/news/26895/valirx-buys-out-finnish-subsidiary-32102.html Thu, 18 Aug 2011 07:47:00 +1000 https://www.proactiveinvestors.com.au/companies/news/26895/valirx-buys-out-finnish-subsidiary-32102.html ValiRx shares jump after successful prostate cancer drug study https://www.proactiveinvestors.com.au/companies/news/26196/valirx-shares-jump-after-successful-prostate-cancer-drug-study-31264.html ValiRx’s most advanced therapeutic, VAL201, not only appears to have the potential to treat hormone-refractory prostate cancer, but also other hormone-induced cancers. The news has added more than quarter to the company’s value so far today

]]>
Thu, 28 Jul 2011 13:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/26196/valirx-shares-jump-after-successful-prostate-cancer-drug-study-31264.html
ValiRx reports successful outcome of study with anti-cancer compound VAL201 https://www.proactiveinvestors.com.au/companies/news/26159/valirx-reports-successful-outcome-of-study-with-anti-cancer-compound-val201-31227.html In the studies thus far, VAL201 has been shown to prevent cancerous growth in live models and cancer cell lines. The response has been shown to be dose dependent.

]]>
Thu, 28 Jul 2011 06:48:00 +1000 https://www.proactiveinvestors.com.au/companies/news/26159/valirx-reports-successful-outcome-of-study-with-anti-cancer-compound-val201-31227.html
Valirx directors buy 2.8 mln shares at 0.63p https://www.proactiveinvestors.com.au/companies/news/25665/valirx-directors-buy-28-mln-shares-at-063p-30629.html Thu, 14 Jul 2011 07:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/25665/valirx-directors-buy-28-mln-shares-at-063p-30629.html ValiRx makes cost-saving development with GeneICE technology https://www.proactiveinvestors.com.au/companies/news/24784/valirx-makes-cost-saving-development-with-geneice-technology-29605.html Tue, 21 Jun 2011 06:35:00 +1000 https://www.proactiveinvestors.com.au/companies/news/24784/valirx-makes-cost-saving-development-with-geneice-technology-29605.html ValiRx gets additional US$510,000 from Volition as ValiBIO sale deal amendend https://www.proactiveinvestors.com.au/companies/news/24484/valirx-gets-additional-us510000-from-volition-as-valibio-sale-deal-amendend-29250.html Fri, 10 Jun 2011 07:02:00 +1000 https://www.proactiveinvestors.com.au/companies/news/24484/valirx-gets-additional-us510000-from-volition-as-valibio-sale-deal-amendend-29250.html ValiRx welcomes Oliver de Giorgio-Miller to board https://www.proactiveinvestors.com.au/companies/news/24203/valirx-welcomes-oliver-de-giorgio-miller-to-board-28901.html Thu, 02 Jun 2011 06:26:00 +1000 https://www.proactiveinvestors.com.au/companies/news/24203/valirx-welcomes-oliver-de-giorgio-miller-to-board-28901.html ValiRx “well positioned” to bring its cancer treatments to clinical trials https://www.proactiveinvestors.com.au/companies/news/24111/valirx-well-positioned-to-bring-its-cancer-treatments-to-clinical-trials-28798.html Tue, 31 May 2011 06:45:00 +1000 https://www.proactiveinvestors.com.au/companies/news/24111/valirx-well-positioned-to-bring-its-cancer-treatments-to-clinical-trials-28798.html Satu Vainikka, from Valirx, talks about the unlimited potential of GeneICE https://www.proactiveinvestors.com.au/companies/news/300855/satu-vainikka-from-valirx-talks-about-the-unlimited-potential-of-geneice-.html Thu, 19 May 2011 09:48:00 +1000 https://www.proactiveinvestors.com.au/companies/news/300855/satu-vainikka-from-valirx-talks-about-the-unlimited-potential-of-geneice-.html ValiRx One2One Investor Presentation - 18th May 2011 https://www.proactiveinvestors.com.au/companies/news/300853/valirx-one2one-investor-presentation-18th-may-2011-758.html Wed, 18 May 2011 09:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/300853/valirx-one2one-investor-presentation-18th-may-2011-758.html Exciting ValiRx already attracting plenty of interest https://www.proactiveinvestors.com.au/companies/news/23682/exciting-valirx-already-attracting-plenty-of-interest--28269.html It is developing a platfom to silence rebellious genes that casue cancer and other diseases, while creating a potentially revenue-generating testing business. Ian Lyall puts biotechnology fledgling ValiRx under the microscope and likes what he sees.

]]>
Mon, 16 May 2011 10:31:00 +1000 https://www.proactiveinvestors.com.au/companies/news/23682/exciting-valirx-already-attracting-plenty-of-interest--28269.html
ValiRx shares motor as it accelerates the development of cancer candidates https://www.proactiveinvestors.com.au/companies/news/22936/valirx-shares-motor-as-it-accelerates-the-development-of-cancer-candidates-27358.html  

Shares in life science group ValiRx rose as much as 25 per cent in a frenetic start to trade as the company said it would accelerate the development of its cancer drug candidates. In doing so it is tying up with researchers from Imperial College London and Oxford University.

 

]]>
Thu, 14 Apr 2011 08:07:00 +1000 https://www.proactiveinvestors.com.au/companies/news/22936/valirx-shares-motor-as-it-accelerates-the-development-of-cancer-candidates-27358.html
ValiRx respond to Which? consumer report on SELFCheck Prostate health test https://www.proactiveinvestors.com.au/companies/news/22671/valirx-respond-to-which-consumer-report-on-selfcheck-prostate-health-test-27038.html Mon, 04 Apr 2011 08:57:00 +1000 https://www.proactiveinvestors.com.au/companies/news/22671/valirx-respond-to-which-consumer-report-on-selfcheck-prostate-health-test-27038.html ValiRx poised for great things after latest product launch and fundraising https://www.proactiveinvestors.com.au/companies/news/22195/valirx-poised-for-great-things-after-latest-product-launch-and-fundraising-26470.html The latest product launch and a fundraising put the biopharmaceutical company on the radar screen of investors.
The group, valued currently at £3 million, has two early stage cancer therapeutic candidates and also develops and markets diagnostics kits.

]]>
Fri, 18 Mar 2011 11:30:00 +1100 https://www.proactiveinvestors.com.au/companies/news/22195/valirx-poised-for-great-things-after-latest-product-launch-and-fundraising-26470.html
ValiRx poised to accelerate research and development programmes https://www.proactiveinvestors.com.au/companies/news/21910/valirx-poised-to-accelerate-research-and-development-programmes-26126.html The latest fundraising provides the company with an opportunity to accelerate the development of its research and development programmes.

]]>
Mon, 07 Mar 2011 08:14:00 +1100 https://www.proactiveinvestors.com.au/companies/news/21910/valirx-poised-to-accelerate-research-and-development-programmes-26126.html
ValiRx after the storm: money in the bank and a strong product in the shops https://www.proactiveinvestors.com.au/companies/news/21454/valirx-after-the-storm-money-in-the-bank-and-a-strong-product-in-the-shops-25580.html The small life science company has had an eventful few days to say the least: It launched a superfast chlamydia self-test on Monday and raised 3.3 million in a placing today to accelerate the development of its lead cancer compounds.  The share price went bananas - there really is no other way to describe it - and today settled, one hopes, at a level 150 percent higher than a week ago, giving the company and investors a well-deserved breather.

]]>
Wed, 16 Feb 2011 08:53:00 +1100 https://www.proactiveinvestors.com.au/companies/news/21454/valirx-after-the-storm-money-in-the-bank-and-a-strong-product-in-the-shops-25580.html
ValiRx shares climb more than 200pct following the launch of Chlamydia home testing kit https://www.proactiveinvestors.com.au/companies/news/21406/valirx-shares-climb-more-than-200pct-following-the-launch-of-chlamydia-home-testing-kit-25515.html Mon, 14 Feb 2011 15:44:00 +1100 https://www.proactiveinvestors.com.au/companies/news/21406/valirx-shares-climb-more-than-200pct-following-the-launch-of-chlamydia-home-testing-kit-25515.html ValiRx: AIM stock out of the Doldrums? https://www.proactiveinvestors.com.au/companies/news/21396/valirx-aim-stock-out-of-the-doldrums-25504.html The market might be seeing a recovery of this AIM midget, whose share price started to rise last week from just under 0.30 pence a share, a level it had held pretty much constantly for the last part of 2010 and into the new year. Today the stock rose even further in reaction to news it has launched its Chlamydia SELFCheck over-the-counter health screening product in the UK.

]]>
Mon, 14 Feb 2011 10:46:00 +1100 https://www.proactiveinvestors.com.au/companies/news/21396/valirx-aim-stock-out-of-the-doldrums-25504.html
ValiRx soars 41% after launching Chlamydia SELFCheck over-the-counter product in UK https://www.proactiveinvestors.com.au/companies/news/21391/valirx-soars-41-after-launching-chlamydia-selfcheck-over-the-counter-product-in-uk-25499.html Mon, 14 Feb 2011 08:43:00 +1100 https://www.proactiveinvestors.com.au/companies/news/21391/valirx-soars-41-after-launching-chlamydia-selfcheck-over-the-counter-product-in-uk-25499.html ValiRx announces funding and partnership agreement https://www.proactiveinvestors.com.au/companies/news/11501/valirx-announces-funding-and-partnership-agreement-14179.html Tue, 09 Mar 2010 07:20:00 +1100 https://www.proactiveinvestors.com.au/companies/news/11501/valirx-announces-funding-and-partnership-agreement-14179.html ValiRx secures £3 million equity credit facility for further development https://www.proactiveinvestors.com.au/companies/news/8976/valirx-secures-3-million-equity-credit-facility-for-further-development-11283.html Fri, 11 Dec 2009 10:41:00 +1100 https://www.proactiveinvestors.com.au/companies/news/8976/valirx-secures-3-million-equity-credit-facility-for-further-development-11283.html ValiRx reports encouraging initial sales at ValiMedix, expects global agreements for diagnostics products https://www.proactiveinvestors.com.au/companies/news/8372/valirx-reports-encouraging-initial-sales-at-valimedix-expects-global-agreements-for-diagnostics-products-10577.html Wed, 25 Nov 2009 09:53:00 +1100 https://www.proactiveinvestors.com.au/companies/news/8372/valirx-reports-encouraging-initial-sales-at-valimedix-expects-global-agreements-for-diagnostics-products-10577.html ValiRx cancer compound patent accepted by Australian regulator https://www.proactiveinvestors.com.au/companies/news/5129/valirx-cancer-compound-patent-accepted-by-australian-regulator-6924.html Wed, 29 Jul 2009 12:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/5129/valirx-cancer-compound-patent-accepted-by-australian-regulator-6924.html ValiRx raises further £200,000 due to strong investors’ demand https://www.proactiveinvestors.com.au/companies/news/3924/valirx-raises-further-200000-due-to-strong-investors-demand-5496.html Tue, 05 May 2009 12:18:00 +1000 https://www.proactiveinvestors.com.au/companies/news/3924/valirx-raises-further-200000-due-to-strong-investors-demand-5496.html ValiRx wins global distribution deals and gets €600,000 from stake sale https://www.proactiveinvestors.com.au/companies/news/2543/valirx-wins-global-distribution-deals-and-gets-600000-from-stake-sale--3773.html Mon, 15 Dec 2008 11:40:00 +1100 https://www.proactiveinvestors.com.au/companies/news/2543/valirx-wins-global-distribution-deals-and-gets-600000-from-stake-sale--3773.html Valirx rockets after announcing successful patent approval in the United States https://www.proactiveinvestors.com.au/companies/news/648/valirx-rockets-after-announcing-successful-patent-approval-in-the-united-states-1046.html proprietary gene-silencing technology, GeneICE, received patent approval from the United States Patent and Trademark Office.

GeneICE compounds have the potential to freeze the development and growth of cancerous cells and could have applications in inflammatory disease and genetic conditions.

Dr Satu Vainikka, CEO of ValiRx, commented:"The US represents the world's most significant oncology market - a dynamic being fuelled by an ageing - and affluent - baby-boomer generation. Through this patent approval, we are now excellently positioned to address this market need."

Shares in ValiRx leapt 78% in early trading.
]]>
Thu, 26 Apr 2007 08:17:00 +1000 https://www.proactiveinvestors.com.au/companies/news/648/valirx-rockets-after-announcing-successful-patent-approval-in-the-united-states-1046.html